Aplagon, a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapeutic platform for thrombo-inflammatory diseases, today announced the appointment ...

While Evommune is terminating development of the oral drug in CSU, trials in AD and migraine prophylaxis will continue.

CDX-622 is a novel, bispecific antibody combining mast cell depletion and TSLP inhibition, two independent pathways contributing to multiple ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

Recently published Chronic Spontaneous Urticaria Market Insights report includes a comprehensive understanding of current ...

By John Vandermosten, CFA NYSE: NSRX READ THE FULL NSRX RESEARCH REPORT Nasus Pharma Ltd. (NYSE: NSRX) held a virtual Key ...

As Elon Musk becomes the world’s first trillionaire, scientists are exploring whether chemical intolerance could help explain some reported health sensitivities.

Is there really a mushroom that can help allergy sufferers? Here's what the research says so far.

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...

TheFly reported on June 10 that UBS increased its price target on CLDX to $45 from $38 while maintaining a Buy rating on the ...

Reishi mushrooms have long been discussed for their health benefits, and many are wondering if the chatter about allergies is ...

Rosie the dog had her tumours treated by an mRNA vaccine developed with the help of artificial intelligence. Her owner had ...